Instead, we observed that NSCLC cells, either A549 cell line or patients-derived primary tumor cells, could efficiently transport their CD39 protein to neighboring T cells via exosome delivery, representing a new mechanism for the increased CD39 expression in activated T cells in TME. This evidence concerns the gene ENTPD1 and neoplasm.